Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1972 Sep;13(9):682-9.
doi: 10.1136/gut.13.9.682.

Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease

Lipid absorption, bile acids, and cholesterol metabolism in patients with chronic liver disease

T A Miettinen. Gut. 1972 Sep.

Abstract

Faecal bile acids and neutral sterols of cholesterol origin were decreased in patients with chronic liver disease, while urinary bile acids were constantly, but never greatly, increased. Thus, production of cholesterol and its conversion to bile acids was decreased in these patients. Faecal fat was only slightly increased, even in cases with a very low bile salt output, but it was negatively correlated with faecal bile acids. The reduced capacity of these patients to synthesize bile acids was shown by the fact that cholestyramine treatment, although it decreased urinary bile acids, increased faecal bile acids only slightly. The resin constantly increased faecal neutral sterols, while the increase of faecal fat was insignificant. Thus, the absorption of fats, as compared with that of sterols, was less strongly reduced by interruption of the enterohepatic circulation of bile salts. In one cirrhotic patient markedly increased faecal bile acids apparently caused cholerrhoeic diarrhoea, which was easily controlled with cholestyramine. The latter consistently increased elimination of cholesterol in cirrhotic patients, but serum cholesterol was not consistently decreased, and in these patients, in contrast to the control subjects, it was difficult to detect changes in cholesterol synthesis with the acetate-mevalonate test and serum methyl sterols.

PubMed Disclaimer

References

    1. J Clin Invest. 1968 Feb;47(2):261-7 - PubMed
    1. Gastroenterology. 1966 Jan;50(1):56-64 - PubMed
    1. J Clin Invest. 1966 Feb;45(2):187-93 - PubMed
    1. Proc Natl Acad Sci U S A. 1967 Sep;58(3):1047-50 - PubMed
    1. Am J Clin Pathol. 1968 Mar;49(3):404-9 - PubMed

MeSH terms

LinkOut - more resources